Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey.

Ann-Marie SvenssonJan EkelundMervete MiftarajBjorn Eliasson

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

The long-term effects and safety of IG300 and ID appear to be very similar in adult patients with type 1 diabetes. The results of this study suggest that these basal insulin analogues may provide benefits compared with the established reference IG100.

Keyphrases

type diabetes
glycemic control
molecular docking
insulin resistance
cross sectional
structure activity relationship
metabolic syndrome
weight loss
young adults